Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
400 | 3455 | 49.1 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RNA INTERFERENCE | Author keyword | 122 | 16% | 20% | 687 |
2 | SIRNA | Author keyword | 110 | 16% | 19% | 651 |
3 | RNAI | Author keyword | 82 | 16% | 14% | 478 |
4 | SIRNA DESIGN | Author keyword | 48 | 100% | 0% | 17 |
5 | SHRNA | Author keyword | 43 | 22% | 5% | 170 |
6 | SMALL INTERFERING RNAS | Author keyword | 41 | 20% | 5% | 186 |
7 | GENE SILENCING | Author keyword | 26 | 13% | 6% | 192 |
8 | U6 PROMOTER | Author keyword | 25 | 66% | 1% | 23 |
9 | SHORT HAIRPIN RNAS | Author keyword | 17 | 24% | 2% | 63 |
10 | ANTIVIRAL GENE THER Y UNIT | Address | 17 | 50% | 1% | 24 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RNA INTERFERENCE | 122 | 16% | 20% | 687 | Search RNA+INTERFERENCE | Search RNA+INTERFERENCE |
2 | SIRNA | 110 | 16% | 19% | 651 | Search SIRNA | Search SIRNA |
3 | RNAI | 82 | 16% | 14% | 478 | Search RNAI | Search RNAI |
4 | SIRNA DESIGN | 48 | 100% | 0% | 17 | Search SIRNA+DESIGN | Search SIRNA+DESIGN |
5 | SHRNA | 43 | 22% | 5% | 170 | Search SHRNA | Search SHRNA |
6 | SMALL INTERFERING RNAS | 41 | 20% | 5% | 186 | Search SMALL+INTERFERING+RNAS | Search SMALL+INTERFERING+RNAS |
7 | GENE SILENCING | 26 | 13% | 6% | 192 | Search GENE+SILENCING | Search GENE+SILENCING |
8 | U6 PROMOTER | 25 | 66% | 1% | 23 | Search U6+PROMOTER | Search U6+PROMOTER |
9 | SHORT HAIRPIN RNAS | 17 | 24% | 2% | 63 | Search SHORT+HAIRPIN+RNAS | Search SHORT+HAIRPIN+RNAS |
10 | RNA INTERFERENCE RNAI | 16 | 22% | 2% | 62 | Search RNA+INTERFERENCE+RNAI | Search RNA+INTERFERENCE+RNAI |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SMALL INTERFERING RNAS | 316 | 32% | 24% | 821 |
2 | SHORT HAIRPIN RNAS | 245 | 63% | 7% | 250 |
3 | FUNCTIONAL SIRNAS | 149 | 98% | 1% | 40 |
4 | DOUBLE STRANDED RNA | 99 | 10% | 27% | 935 |
5 | SIRNAS | 86 | 33% | 6% | 213 |
6 | SIRNA | 84 | 23% | 9% | 323 |
7 | IN VIVO DELIVERY | 75 | 45% | 4% | 127 |
8 | HAIRPIN RNAS | 72 | 54% | 3% | 94 |
9 | SHORT INTERFERING RNAS | 64 | 36% | 4% | 146 |
10 | STABLE SUPPRESSION | 61 | 82% | 1% | 36 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OLIGONUCLEOTIDES | 8 | 17% | 1% | 45 |
2 | NUCLEIC ACID THERAPEUTICS | 3 | 13% | 1% | 25 |
3 | MOLECULAR THERAPY-NUCLEIC ACIDS | 3 | 11% | 1% | 24 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The promises and pitfalls of RNA-interference-based therapeutics | 2009 | 548 | 93 | 57% |
Preclinical and clinical development of siRNA-based therapeutics | 2015 | 5 | 110 | 53% |
Interfering with disease: a progress report on siRNA-based therapeutics | 2007 | 586 | 100 | 72% |
Current prospects for RNA interference-based therapies | 2011 | 260 | 161 | 50% |
RNA-Based Therapeutics: Current Progress and Future Prospects | 2012 | 216 | 68 | 44% |
Strategies for silencing human disease using RNA interference | 2007 | 515 | 86 | 67% |
Molecular Mechanisms of RNA Interference | 2013 | 100 | 96 | 42% |
RNAi therapeutics: a potential new class of pharmaceutical drugs | 2006 | 462 | 75 | 80% |
RNA interference in the clinic: challenges and future directions | 2011 | 220 | 93 | 41% |
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application | 2010 | 246 | 110 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTIVIRAL GENE THER Y UNIT | 17 | 50% | 0.7% | 24 |
2 | SKIP ACKERMAN MOL THER EUT | 10 | 73% | 0.2% | 8 |
3 | GLOBAL RNAI MED | 6 | 37% | 0.4% | 13 |
4 | DROSOPHILA RNAI SCREENING | 6 | 47% | 0.3% | 9 |
5 | GLOBAL PHARMACEUT ANALYT SCI | 4 | 67% | 0.1% | 4 |
6 | CINIMA MED | 4 | 75% | 0.1% | 3 |
7 | RNA THER EUT | 3 | 19% | 0.4% | 14 |
8 | HEPATITIS B VIRUS UNIT | 3 | 60% | 0.1% | 3 |
9 | SECT INFECT DIS IMMUNOBIOL | 3 | 60% | 0.1% | 3 |
10 | VIRUS ENTEROTROPES STRATEGIES ANTIVIRALES | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000166716 | SMALL ACTIVATING RNA//SARNA//RNA ACTIVATION |
2 | 0.0000129046 | SYSTEMIC RNAI//K STATE ARTHROPOD GENOM//DSRNA FEEDING |
3 | 0.0000089427 | PIRNA//PIWI//PIRNAS |
4 | 0.0000087447 | GW182//DROSHA//ARGONAUTE |
5 | 0.0000073821 | RNA SILENCING//POST TRANSCRIPTIONAL GENE SILENCING//VIRUS INDUCED GENE SILENCING |
6 | 0.0000073510 | O I//VIRAL MICRORNAS//VIRAL MIRNA |
7 | 0.0000063808 | GENE DELIVERY//POLYETHYLENIMINE//POLYPLEX |
8 | 0.0000055916 | REVERSE TRANSFECTION//SUBSTRATE MEDIATED DELIVERY//SUBSTRATE MEDIATED |
9 | 0.0000047805 | EXON SKIPPING//DMD GENET THER Y GRP//MC LOCKWOOD MUSCULAR DYSTROPHY |
10 | 0.0000040885 | HYDRODYNAMICS BASED PROCEDURE//HYDRODYNAMICS BASED TRANSFECTION//HYDRODYNAMIC DELIVERY |